Cigarette Smoking: Associated Oxidative Stress and Health Hazards
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: closed (15 April 2023) | Viewed by 29682
Special Issue Editors
2. Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia
Interests: chronic respiratory diseases; animal models; lung microbiome; inflammasomes; miRNA
2. Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia
Interests: chronic respiratory diseases; in vitro assays; cellular and molecular biology; pharmacology; animal models; lung cancer
Special Issues, Collections and Topics in MDPI journals
2. Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia
Interests: chronic respiratory diseases; oxidative stress; mitochondrial dysfunction; pharmacology; pre-clinical animal models
Special Issue Information
Dear Colleagues,
Tobacco use is one of the most significant public health hazards facing today's world. According to a report by the World Health Organization, tobacco kills half of its users. Approximately 8 million tobacco users (7 million direct users and 1.2 million exposed to second-hand smoke) die each year owing to different health complications. Among the types of tobacco use, cigarette smoking is the most common. Typically, cigarette smoke (CS) contains thousands of harmful chemicals, such as reactive oxygen species (ROS), tar, and particulate matter, which result in the orchestration of disease-related symptoms. Tobacco smoking is the primary risk factor for the development of chronic inflammatory lung diseases (asthma, chronic obstructive pulmonary disease). Chronic exposure to cigarette smoke activates different cellular pathways that result in inflammation, cellular metabolic shifts, oxidative stress, protease–antiprotease, and cellular apoptosis in the lungs. In addition to chronic lung diseases, cigarette smoking leads to the development of cardiovascular diseases. According to the literature, cigarette smoking doubles the risk of developing acute myocardial infarction, cerebrovascular disease, and heart failure. Further, the association of cigarette smoking with the development of chronic kidney diseases is now known. Accordingly, research is ongoing to better understand the molecular impact of cigarette smoke exposure and to develop new therapeutics.
This Special Issue aims to cover the recent in vitro, in vivo, and clinical research updates in the field of cigarette-smoke-induced health disorders. Original articles, short communications, and reviews related to these topics are welcome for submission.
Prof. Dr. Philip M. Hansbro
Dr. Keshav Raj Paudel
Dr. Vivek Dharwal
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chronic respiratory diseases
- cigarette smoking
- animal model
- in vitro
- clinical study
- oxidative stress
- antioxidants
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.